A systematic review of immune checkpoint inhibitors in endometrial cancer
Na Zhu, Chaihong Zhang · 2026
Read A systematic review of immune checkpoint inhibitors in endometrial cancer by Na Zhu, Chaihong Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13284135.txt.
Description
Na Zhu and Chaihong Zhang mapped the research literature in 2026 on immune checkpoint inhibitors for endometrial cancer, a common womb cancer. Checkpoint drugs release brakes on immune cells so they can attack tumours. Using bibliometric methods on two databases, the team charted papers from 2015 to 2024, counting who publishes, where, and on what themes.
One database held 829 papers across 296 journals from 63 countries, and the other held 279. The United States, China, and Italy led output, and the strongest partnership ran between the United States and England. Hot topics included mismatch repair deficiency, the PD-1 and PD-L1 markers, and drugs such as pembrolizumab and dostarlimab. One author and one cancer centre stood out as most influential.
Catalog record
| CREATOR | Na Zhu, Chaihong Zhang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 85 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |